CD1D and myeloid sarcoma: In contrast NKT-cells expressing the invariant Vα24Jα18+ T-cell receptor identified by specific receptor antibody and CD1d-tetrameric PBS57-loaded complexes, were increased in MS patients compared with healthy subjects.